1-6 of 6
Jianbo Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT289: A phase II study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in patients with HER2-positive metastatic solid tumors and metastases to brain (TUCATEMEB)

Ecaterina E. Dumbrava, Amber M. Kennon, Rashmi K. Murthy, Emma J. Montazari, Hussein Tawbi, Jing Li, Frederick F. Lang, Gisela Sanchez, Jianbo Wang, Isabella C. Glitza, Barbara J. O'Brien, Thomas Beckham, Todd Swanson, Martin C. Tom, Uyen M. Vu, Tanisha T. Darko, Tiantian Cai, Komal Shah, Funda Meric-Bernstam, Jordi Rodon
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): CT289.
https://doi.org/10.1158/1538-7445.AM2024-CT289
Published: 05 April 2024
View article titled, Abstract CT289: A phase II study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in patients with HER2-positive metastatic solid tumors and metastases to brain (TUCATEMEB)
Journal Articles

Abstract CT292: Phase II study of pembrolizumab in combination with lenvatinib in patients with triple negative breast cancer (TNBC), non-small cell lung cancer (NSCLC), and other tumor types and brain metastases

Ecaterina E. Dumbrava, Emma J. Montazari, Uyen M. Vu, Tiantian Cai, Mehmet Altan, Nuhad K. Ibrahim, Debra N. Yeboa, Jing Li, Frederick F. Lang, Gisela Sanchez, Isabella C. Glitza, Barbara J. O'Brien, Rashmi K. Murthy, Jianbo Wang, Tanisha T. Darko, Denisse Velazquez, Komal Shah, Funda Meric-Bernstam, Hussein Tawbi, Jordi Rodon
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): CT292.
https://doi.org/10.1158/1538-7445.AM2024-CT292
Published: 05 April 2024
View article titled, Abstract CT292: Phase II study of pembrolizumab in combination with lenvatinib in patients with triple negative breast cancer (TNBC), non-small cell lung cancer (NSCLC), and other tumor types and brain metastases
Journal Articles

Abstract 4166: TSPO-targeted near-infrared optical probe for early identification and localization of high-risk premalignant pancreatic lesions

Shilpa Sharma, Denise Hernandez, Xiaoxia Wen, Jianbo Wang, Cong-Dat Pham, Beibei Huang, Henry Charles Manning
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4166.
https://doi.org/10.1158/1538-7445.AM2024-4166
Published: 22 March 2024
View article titled, Abstract 4166: TSPO-targeted near-infrared optical probe for early identification and localization of high-risk premalignant pancreatic lesions
Journal Articles

Abstract 5230: Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia

Qimei Han, Jianbo Wang, Austin Y. Shull, Fang Shi, Libin Deng, Jeong-Hyeon Choi, Eun-Jeong Park, Shuo Tu, Lirong Pei, Farrukh T. Awan, Roni Bollag, Locke J. Bryan, Hong-bo Xin, Chandraiah Lagisetti, Thomas R. Webb, Victor Jin, Huidong Shi
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 5230.
https://doi.org/10.1158/1538-7445.AM2019-5230
Published: 01 July 2019
View article titled, Abstract 5230: Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia
Journal Articles

RNA Helicase DDX5 Is a p53-Independent Target of ARF That Participates in Ribosome Biogenesis

Anthony J. Saporita, Hsiang-Chun Chang, Crystal L. Winkeler, Anthony J. Apicelli, Raleigh D. Kladney, Jianbo Wang, R. Reid Townsend, Loren S. Michel, Jason D. Weber
Journal: Cancer Research
Cancer Res (2011) 71 (21): 6708–6717.
https://doi.org/10.1158/0008-5472.CAN-11-1472
Published: 30 October 2011
View article titled, RNA Helicase DDX5 Is a p53-Independent Target of ARF That Participates in Ribosome Biogenesis
Open the PDF for RNA Helicase DDX5 Is a p53-Independent Target of ARF That Participates in Ribosome Biogenesis in another window
Includes: Supplementary data
Journal Articles

Synthetic Lethality through Combined Notch–Epidermal Growth Factor Receptor Pathway Inhibition in Basal-Like Breast Cancer

Yiyu Dong, Aimin Li, Jianbo Wang, Jason D. Weber, Loren S. Michel
Journal: Cancer Research
Cancer Res (2010) 70 (13): 5465–5474.
https://doi.org/10.1158/0008-5472.CAN-10-0173
Published: 30 June 2010
View article titled, Synthetic Lethality through Combined Notch–Epidermal Growth Factor Receptor Pathway Inhibition in Basal-Like Breast Cancer
Open the PDF for Synthetic Lethality through Combined Notch–Epidermal Growth Factor Receptor Pathway Inhibition in Basal-Like Breast Cancer in another window
Includes: Supplementary data